Section I
201 – 210 of 4893
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
(
- Contribution to journal › Scientific review
-
Mark
Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
MOSkin dosimetry for an ultra-high dose-rate, very high-energy electron irradiation environment at PEER
(
- Contribution to journal › Article
-
Mark
”Being ill was the easy part” : exploring cancer survivors’ reactions to perceived challenges in engaging with primary healthcare
(
- Contribution to journal › Article
-
Mark
Preliminary evaluation of an automated autoencoder-UNet pipeline for chemical image segmentation and compression with reference to serial ground truth pathology
2024) Data Science for Photonics and Biophotonics 2024 In Proceedings of SPIE - The International Society for Optical Engineering 13011.(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma : A Danish observational population-based study
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of proton beam therapy vs. conventional radiotherapy for patients with brain tumors in Sweden : results from a non-randomized prospective multicenter study
(
- Contribution to journal › Article
-
Mark
Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells
(
- Contribution to journal › Article
-
Mark
Evaluating the Efficacy and Complications of the Scapular Osseous Free Flap for Head and Neck Reconstruction : Results from a Population-based Cohort
(
- Contribution to journal › Article
-
Mark
Targeting IGF-IR improves neoadjuvant chemotherapy efficacy in breast cancers with low IGFBP7 expression
(
- Contribution to journal › Article